跳至主要内容
临床试验/NCT00013143
NCT00013143
已完成
不适用

Patient Profiling and Provider Feedback to Reduce Adverse Drug Events

US Department of Veterans Affairs1 个研究点 分布在 1 个国家目标入组 1,200 人2001年6月

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Adverse Drug Events
发起方
US Department of Veterans Affairs
入组人数
1200
试验地点
1
状态
已完成
最后更新
11年前

概览

简要总结

Adverse drug events (ADE) present a unique focus for error reduction. Computerized provider order entry, with embedded clinical decision support, has great promise in reducing medication errors but preventable adverse drug events may still occur despite such systems.

详细描述

Background: Adverse drug events (ADE) present a unique focus for error reduction. Computerized provider order entry, with embedded clinical decision support, has great promise in reducing medication errors but preventable adverse drug events may still occur despite such systems. Objectives: The purpose of the study was to evaluate whether adding medication profiling (by using a retrospective drug utilization review program) to computerized provider order entry with embedded order checks (drug alerts) reduces the incidence of adverse drug events. Methods: Medication profiles mainly focused on possible drug-drug and drug-disease interactions, with some drug duplications. To do the medication profiles we licensed a proprietary computerized retrospective drug utilization review system. We randomly assigned over 900 patients to Usual Care or Provider Feedback. For patients in the latter group, selected providers were contacted by letter with pertinent information; electronic mail was used for follow-up contact. Clinical and other relevant data was retrospectively abstracted from the medical records for up to one year from the last medication profile for all patients. This was done by a pharmacist reviewer, using a study-derived instrument, and blinded to patient assignment. ADE incidence is the primary outcome of interest, with other outcomes such as ADE severity and preventability also assessed. We also developed and implemented provider surveys in pre- and post-profiling periods. Status: Pre and post survey results published. Adjunct study on clinical actions as a result of drug alerts published. Main study (profiling): manuscript in proces.

注册库
clinicaltrials.gov
开始日期
2001年6月
结束日期
2003年1月
最后更新
11年前
研究类型
Interventional
研究设计
Single Group
性别
All

研究者

责任方
Sponsor

入排标准

入选标准

  • patient must be alive
  • patient must be currently active in GLA system
  • medication for which alert was generated must be currently active
  • patient provider must not be Peter Glassman

排除标准

  • 未提供

结局指标

主要结局

未指定

研究点 (1)

Loading locations...

相似试验